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1) Awale S., Hamazaki T., Kadowaki M., Saiki I., Tezuka Y., and Kadota S.: Chapter IV. 
Commonly Encountered Diseases in Traditional Medicine, In Myanmar Traditional 
Medicine Handbook, by Department of Traditional Medicine, Ministry of Health, and Japan 
International Cooperation Agency (JICA), 89–120, 2008.  
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1) Awale S., Li F., Onozuka H., Esumi H., Tezuka Y., and Kadota S.: Constituents of Brazilian 
Red Propolis and their Preferential Cytotoxic Activity against Human Pancreatic Cancer 
PANC-1 Cell Line in Nutrient Deprived Condition. Bioorg. Med. Chem., 16: 181–189, 2008. 
Abstract: Human pancreatic cancer cells such as PANC-1 are known to exhibit marked tolerance to 
nutrition starvation that enables them to survive for prolonged period of time even under extremely 
nutrient-deprived conditions. Thus, elimination of this tolerance to nutrition starvation is regarded as a 
novel approach in anticancer drug development. In this study, the MeOH soluble extract of Brazilian red 
propolis was found to kill 100% PANC-1 cells preferentially in the nutrient-deprived condition at the 
concentration of 10 Pg/mL. Further phytochemical investigation led to the isolation of 43 compounds 
including three new compounds, (6aS,11aS)-6a-ethoxymedicarpan (1), 2-(2’,4’-dihydroxyphenyl)- 
3-methyl-6-methoxybenzofuran (2), and 2,6-dihydroxy-2-[(4-hydroxyphenyl)methyl]-3-benzofuranone 
(3). Among them, (6aR,11aR)-3,8-dihydroxy-9-methoxypterocarpan (21, DMPC) displayed the most 
potent 100% preferential cytotoxicity (PC100) at the concentration of 12.5 PM. Further study on the mode 
of cell death induced by DMPC against PANC-1 cells indicated that killing process was not accompanied 
by DNA fragmentation, rather through a nonapoptotic pathway accompanied by necrotic-type 
morphological changes.  
2) Toyooka N., Zhou D., Kobayashi S., Tsuneki H., Wada T., Sakai H., Nemoto H., Sasaoka T., 
Tezuka Y., Subehan, Kadota S., Garraffo H. M., Spande T. F., and Daly J. W.: Synthesis of 
the Proposed Structures of Poison-Frog Alkaloids 179 and 207E and Their Inhibitory Effects 
on Neuronal Nicotinic Acetylcholine Receptors. Synlett, 61–64, 2008.  
3) Win N. N., Awale S., Esumi H., Tezuka Y., and Kadota S.: Panduratins D—I, Novel 
Secondery Metabolites from Rhizomes of Boesenbergia pandurata. Chem. Pharm. Bull., 56: 
491–496, 2008.  
Abstract: Investigation of the non-polar fraction of Boesenbergia pandurata of Myanmar led to the 
identification of six novel secondary metabolites, panduratins D–I (1–6), together with known 
diastereomers, panduratins B1 (7) and B2 (8). Their structures were determined based on extensive 
spectroscopic analysis. The in vitro preferential cytotoxicity of all isolates was examined against human 
pancreatic PANC-1 cancer cells under nutrient-deprived conditions. All exhibited a mild activity.  
4) Yin J., Han N., Xu X., Liu Z., Zhang B., and Kadota S.: Inhibitory activity of the ethyl 
acetate fraction from Viscum coloratum on bone resorption. Planta Med., 74: 120–125, 2008. 
5) Li F., Awale S., Tezuka Y., and Kadota S.: Cytotoxic constituents from Brazilian red propolis 
and their structure–activity relationship. Bioorg. Med. Chem., 16: 5434–5440, 2008.  
Abstract: Several classes of flavonoids [flavanoids (1–10), flavonol (11), isoflavones (12–18),
isoflavanones (19–22), isoflavans (23–26), chalcones (27–30), auronol (31), pterocarpans (32–37),
2-arylbenzofuran (38), and neoflavonoid (39)] and lignans (40–42) isolated from the MeOH extract of 
Brazilian red propolis were investigated for their cytotoxic activity against a panel of six different cancer 
cell lines including murine colon 26-L5 carcinoma, murine B16-BL6 melanoma, murine Lewis lung 
carcinoma, human lung A549 adenocarcinoma, human cervix HeLa adenocarcinoma, and human 
HT-1080 fibrosarcoma cell lines. Based on the observed results, structure㵨activity relationships were 
discussed. Among the tested compounds, 7-hydroxy-6-methoxyflavanone (3) exhibited the most potent 
activity against B16-BL6 (IC50, 6.66 PM), LLC (IC50, 9.29 PM), A549 (IC50, 8.63 PM), and HT-1080 
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(IC50, 7.94 PM) cancer cell lines, and mucronulatol (26) against LLC (IC50, 8.38 PM) and A549 (IC50, 9.9 
PM) cancer cell lines. These activity data were comparable to those of the clinically used anticancer drugs, 
5-fluorouracil and doxorubicin, against the tested cell lines, suggesting that 3 and 26 are the good 
candidates for future anticancer drug development.  
6) Yin J., Han N., Liu Z., Xu X., Zhang B., and Kadota S.: The in vitro anti-osteoporotic activity 
of some diarylheptanoids and lignans from the rhizomes of Dioscorea spongiosa. Planta 
Med., 74: 1451–1453, 2008.  
7) Win N. N., Awale S., Esumi H., Tezuka Y., and Kadota S.: Novel anticancer agents, 
kayeassamins A and B from the flower of Kayea assamica of Myanmar. Bioorg. Med. Chem. 
Lett., 18: 4688–4691, 2008.  
Abstract: The CHCl3-soluble fraction of 70% EtOH extract of the flower of Kayea assamica completely 
killed human pancreatic PANC-1 cancer cells preferentially under nutrient-deprived conditions at 1 
Pg/mL. Bioassay-guided fractionation and isolation afforded two novel compounds, kayeassamins A (1)
and B (2). Their structures were elucidated using extensive spectroscopic methods and the modified 
Mosher method. Each compound showed 100% preferential cytotoxicity (PC100) against PANC-1 cells 
under nutrient-deprived conditions at 1 PM. Furthermore, both compounds inhibited the migration of 
PANC-1 cells in the wound closure assay.  
8) Toyooka N., Zhou D., Nemoto H., Tezuka Y., Kadota S., Jones T. H., Garraffo H. M., Spande 
T. F., and Daly J. W.: First Enantioselective Synthesis of a Hydroxyindolizidine Alkaloid 
from the Ant Myrmicaria melanogaster. Synlett, 1894–1896, 2008.  
9) Win N. N., Awale S., Esumi H., Tezuka Y., and Kadota S.: Novel anticancer agents, 
kayeassamins CгI from the flower of Kayea assamica of Myanmar. Bioorg. Med. Chem., 16: 
8653–8660, 2008.  
Abstract: A CHCl3-soluble fraction of 70% EtOH extract of the flower of Kayea assamica from 
Myanmar exhibited 100% preferential cytotoxicity (PC100) against human pancreatic cancer PANC-1 cells 
under nutrient-deprived conditions at 1 Pg/mL. Bioassay-guided fractionation and isolation afforded nine 
new coumarins, kayeassamins A (8), B (9), and C–I (1–7), together with nine known coumarins (10–18).
The structures of these compounds were identified by extensive spectroscopic techniques as well as by 
comparison with published data. Absolute configuration at C-1’ of 1 was established as S-configuration by 
the modified Mosher method. All the isolates were evaluated for their in vitro preferential cytotoxicity 
using novel anti-austerity strategy. Among them, the novel coumarins, kayeassamins A (8), B (9), D (2), E 
(3), and G (5) exhibited the most potent preferential cytotoxicity (PC100 1 PM) in a concentration- and 
time-dependent manner and induced apoptosis-like morphological changes of PANC-1 cells within 24 h 
of treatment. Based on the observed cytotoxicity, structure-activity relationships have been established.  
10) Subehan, Kadota S., and Tezuka Y.: In Vitro Mechanism-based Inactivation of Cytochrome 
P450 3A4 by a New Constituent of Cinnamomum burmani. Planta Med., 74: 1474–1480, 
2008.  
Abstract: Cytochrome P450 enzymes play an important role in drug metabolism. Various studies have 
reported the potential inhibition of these enzymes by natural compounds, leading to possible drug–herb 
interaction. One study reported that the MeOH extract of Cinnamomum burmani inhibited CYP3A4 in a 
mechanism-based mode. Further phytochemical investigation on this plant led to the isolation of 17 
compounds including 2 new compounds: cinnamic aldehyde cyclic syringylglycerol 1,3-acetal (1) and 
5'-hydroxy-5-hydroxymethyl-4'',5''-methylenedioxy-1,2,3,4-dibenzo-1,3,5-cycloheptatriene (2). The 
isolated constituents were tested for their preincubation time-dependent inhibition of CYP3A4 at 0 and 20 
min. Only the new compound 2 showed an increase in the inhibitory activity to >50 % after 20-min 
preincubation. Further investigations of the inactivation by 2 displayed characteristics of a 
mechanism-based inactivator, with KI and kinact values of 7.7 PM and 0.04 min–1, respectively.  
㩷 㩷
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